GlycoMimetics, Inc. Announces Sudden Passing Of Board Director And Audit Committee Member William Gust

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlycoMimetics, Inc. (NASDAQ: GLYC) reported today with great sorrow the sudden passing of William “Bill” Gust, who had served as a director of the company since 2006 and as a member of the audit committee of the Company’s board of directors.

“Bill was one of the first investors in GlycoMimetics. We greatly appreciate his early support of the Company, as well as the advice and counsel provided to us over the years that he served on our Board. We will miss him,” said Rachel King, Chief Executive Officer of GlycoMimetics.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC